Clearbridge Investments LLC reduced its position in MAXIMUS, Inc. (NYSE:MMS) by 10.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,514,209 shares of the health services provider’s stock after selling 173,013 shares during the period. Clearbridge Investments LLC’s holdings in MAXIMUS were worth $108,387,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Amundi Pioneer Asset Management Inc. purchased a new stake in MAXIMUS during the fourth quarter valued at approximately $163,000. Steward Partners Investment Advisory LLC purchased a new stake in MAXIMUS during the fourth quarter valued at approximately $169,000. Capital One National Association purchased a new stake in MAXIMUS during the fourth quarter valued at approximately $213,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in MAXIMUS by 51.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,581 shares of the health services provider’s stock valued at $256,000 after purchasing an additional 1,214 shares during the period. Finally, Parametrica Management Ltd purchased a new stake in MAXIMUS during the fourth quarter valued at approximately $292,000. Institutional investors own 95.67% of the company’s stock.
Shares of MAXIMUS, Inc. (MMS) opened at $69.00 on Monday. MAXIMUS, Inc. has a 52-week low of $57.12 and a 52-week high of $72.71. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.57 and a current ratio of 2.57. The stock has a market capitalization of $4,500.39, a P/E ratio of 20.54, a price-to-earnings-growth ratio of 2.30 and a beta of 1.18.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th were issued a $0.045 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.26%. MAXIMUS’s payout ratio is 5.36%.
In other news, Director Russell A. Beliveau sold 1,000 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total value of $71,730.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, General Counsel David Francis sold 3,600 shares of the stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $64.50, for a total value of $232,200.00. Following the completion of the sale, the general counsel now owns 10,017 shares in the company, valued at $646,096.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 47,300 shares of company stock worth $3,209,230. Company insiders own 3.10% of the company’s stock.
A number of equities research analysts have issued reports on the company. Canaccord Genuity decreased their price objective on MAXIMUS from $71.00 to $65.00 and set a “hold” rating on the stock in a research report on Friday, February 9th. Maxim Group restated a “hold” rating and set a $69.00 price objective (up from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. Finally, Zacks Investment Research upgraded MAXIMUS from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. MAXIMUS presently has an average rating of “Hold” and a consensus price target of $66.60.
TRADEMARK VIOLATION WARNING: This article was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/3256902/maximus-inc-mms-shares-sold-by-clearbridge-investments-llc.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.